Mission Bio, a US-based precision medicine and genomics spinout from University of California, San Francisco (UCSF), closed a $10m series A round yesterday backed by the Stanford University-affiliated Stanford-Start X fund.
The round was led by venture capital firm Mayfield Fund, with contributions from angel investment vehicles Keiretsu Forum, Tech Coast Angels and Life Science Angels.
Mission Bio has created a genomics-based analytics platform called Tapestri that has the potential to process as many as 10,000 cells while distinguishing each…